Home Immunocore

Immunocore

In operation
Post-IPO Round
Biological Therapy Developer
Basic
Enterprise Profile

Basic Information

Immunocore is a leading T-cell receptor (TCR) biotechnology company committed to developing first-class biologics to address the needs of patients with cancer, infectious diseases, and autoimmune disorders.
Immunocore Limited
Oxford,England,United Kingdom
101~500 people
January 01, 2008
info@immunocore.com

Enterprise Profile

Industrial Sector
New Drug Development Immune Cell Therapy
Technology
Gene Technology Biotechnology
Concept
Tumor
Application Scenarios
Innovative Drugs Bispecific Antibody